Brief: DocMorris FY OTC Revenues Up By 6.7%
Jan 21 (Reuters) - DOCMORRIS AG DOCM.S :
* GROWS 6.7 PER CENT IN 2024 AND ACCELERATES RX GROWTH IN
THE
FOURTH QUARTER
* FY OTC REVENUES INCREASE BY 6.7 PER CENT IN 2024
* CASH POSITION OF CHF 95 MILLION AT END OF 2024
* NEW RX CUSTOMERS GREW FIVEFOLD AND RX REVENUE UP 16.6 PER
CENT
IN Q4 OF 2024
* OUTLOOK 2024 CONFIRMED
Source text: ID:nEQ4z52Yya
Further company coverage: DOCM.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on DocMorris AG
See all newsEurope Research Roundup: Barclays, Societe Generale, UBS Group
Europe Research Roundup: Barclays, Societe Generale, UBS Group
Brief: Shareholder CEPD Says It Rejects DocMorris' Mischaracterisation And Emphasizes Case For Real Governance Reform
DocMorris rises on 'strong' Q1 results
Brief: Docmorris Says Qtrly Revenue Rose By 11.7 Per Cent To CHF 303.8 Million